BAC vs FHB: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BAC and FHB share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BAC and FHB exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Bank of America is the second-largest US bank by assets, behind JPMorgan Chase. The company is one of the four mega-bank holding companies (along with JPMorgan, Citigroup, and Wells Fargo) and operates across four main reporting segments. Consumer Banking is the largest retail bank in the US by deposits, serving over 60 million customers through ~3,800 branches. Global Wealth and Investment Management is one of the largest US wealth managers (anchored by Merrill Lynch). Global Banking provides commercial banking, treasury services, and investment banking to corporate and institutional clients. Global Markets provides trading services across fixed income, equities, and commodities.

Full BAC guide

First Hawaiian, Inc. (NASDAQ: FHB) is the parent of First Hawaiian Bank, founded in 1858 as Bishop & Company and the oldest financial institution in Hawaii. The bank runs a full-service network across Hawaii, Guam, and Saipan with roughly 60 branches, organized into Retail Banking, Commercial Banking, and Treasury segments. It has held the number one deposit market share in Hawaii for well over a decade (historically in the mid-30s percent range), giving it a low-cost, sticky funding base. As of Q1 2026 it reported about $24.3 billion in total assets and roughly $20.8 billion in deposits.

Full FHB guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• BAC drivers: Net interest income from deposit franchise; Investment banking and trading recovery.
• FHB drivers: Deposit franchise and funding advantage; Net interest margin and rate sensitivity.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Credit quality is the eternal bank risk; consumer and commercial credit losses rise cyclically. For FHB, fHB's business is geographically concentrated in Hawaii, Guam, and Saipan, so a downturn in Hawaii tourism, employment, or real estate would hit loan demand and credit quality at once.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick BAC if you believe its drivers more; FHB if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BAC and FHB guides.

BAC. BAC trades at a modest multiple typical of large US banks, about 12.5x trailing and 10x forward earnings after the October 2026 sell-off. The valuation balances the deposit franchise, rising net interest income, and wealth growth against a costly AML settlement, softer trading, and credit-cycle uncertainty. Analysts still rate it a strong buy with an average target near $63, and the next report is due January 15, 2027.

FHB. FHB trades near 10.9x trailing and 9.9x forward earnings and about 1.1x book value, a little cheaper than in mid-2026 after a ~14% slide over the past three months, with a dividend yield near 4.2%. Trailing EPS is ~$2.30 and analysts expect ~$2.36 for 2026. The valuation reflects a stable, high-share deposit franchise with limited growth rather than a rerating catalyst, and the October 23 quarter is the next data point on margins and credit.

Headline figures (approximate, October 2026): BAC shows revenue (ttm) ~$115 billion; Q3 2026 revenue up ~7% YoY, net income (ttm) ~$30.8 billion; Q3 2026 ~$6.5 billion (down from ~$8.0 billion), eps ~$4.19 (TTM); Q3 2026 $0.91 reported, ~$1.08 ex-settlement, vs ~$1.10 expected, net interest income ~$16.6 billion in Q3 2026 (up ~8% YoY); net interest yield 2.16%; FHB shows market cap ~$3.05 billion (share price ~$25.06), revenue (ttm) ~$881 million (latest quarter ~+6% yoy), net income (ttm) ~$285 million (profit margin ~32%), net income (q2 2026) ~$73.4 million (EPS ~$0.60 vs ~$0.59 expected).

BAC and FHB are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BAC and FHB exposure against your real portfolio. It is not an investment adviser.